pemafibrate
Kowa Pharmaceuticals
[]
as we saw from the earlier press release, now presented #aha22 and published - no cv event reduction from pemafibrate v placebo 
Dir of Prev Cardiology @MassGeneralNews | Assoc Prof @harvardmed | Assoc Mem @broadinstitute | Assoc Ed @JAMACardio @ScienceAdvances